The global PET Radiopharmaceuticals market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the PET Radiopharmaceuticals production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of PET Radiopharmaceuticals by regions (countries) and by Application.
The global PET Radiopharmaceuticals market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global PET Radiopharmaceuticals market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise PET Radiopharmaceuticals markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global PET Radiopharmaceuticals market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global PET Radiopharmaceuticals market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global PET Radiopharmaceuticals market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global PET Radiopharmaceuticals market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global PET Radiopharmaceuticals market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global PET Radiopharmaceuticals market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global PET Radiopharmaceuticals market by each application segment for the same period.
This report includes the following manufacturers:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Market Segment by Type
F-18
Ru-82
Others
Market Segment by Application
Oncology
Cardiology
Neurology
Others
Research Methodology
To compile the detailed study of the global PET Radiopharmaceuticals market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the PET Radiopharmaceuticals market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the PET Radiopharmaceuticals market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
In terms of production side, this report researches the PET Radiopharmaceuticals production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of PET Radiopharmaceuticals by regions (countries) and by Application.
The global PET Radiopharmaceuticals market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global PET Radiopharmaceuticals market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise PET Radiopharmaceuticals markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global PET Radiopharmaceuticals market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global PET Radiopharmaceuticals market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global PET Radiopharmaceuticals market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global PET Radiopharmaceuticals market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global PET Radiopharmaceuticals market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global PET Radiopharmaceuticals market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global PET Radiopharmaceuticals market by each application segment for the same period.
This report includes the following manufacturers:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Market Segment by Type
F-18
Ru-82
Others
Market Segment by Application
Oncology
Cardiology
Neurology
Others
Research Methodology
To compile the detailed study of the global PET Radiopharmaceuticals market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the PET Radiopharmaceuticals market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the PET Radiopharmaceuticals market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 F-18
1.2.3 Ru-82
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global PET Radiopharmaceuticals Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global PET Radiopharmaceuticals Market Size (2016-2027)
2.1.1 Global PET Radiopharmaceuticals Revenue (2016-2027)
2.1.2 Global PET Radiopharmaceuticals Sales (2016-2027)
2.2 Global PET Radiopharmaceuticals Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global PET Radiopharmaceuticals Sales by Regions (2016-2021)
2.2.2 Global PET Radiopharmaceuticals Revenue by Regions (2016-2021)
2.3 Global PET Radiopharmaceuticals Market Size Forecast by Region
2.3.1 Global PET Radiopharmaceuticals Sales Forecast by Region (2022-2027)
2.3.2 Global PET Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4 Global Top PET Radiopharmaceuticals Regions (Countries) Ranking by Market Size
2.5 PET Radiopharmaceuticals Industry Trends
2.5.1 PET Radiopharmaceuticals Market Trends
2.5.2 PET Radiopharmaceuticals Market Drivers
2.5.3 PET Radiopharmaceuticals Market Challenges
2.5.4 PET Radiopharmaceuticals Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top PET Radiopharmaceuticals Manufacturers by Sales (2016-2021)
3.1.1 Global PET Radiopharmaceuticals Sales by Manufacturers (2016-2021)
3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by PET Radiopharmaceuticals Sales in 2020
3.2 Global Top Manufacturers PET Radiopharmaceuticals by Revenue
3.2.1 Global PET Radiopharmaceuticals Revenue by Manufacturers (2016-2021)
3.2.2 Top PET Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.2.3 Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
3.2.4 Global PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2020)
3.4 Global PET Radiopharmaceuticals Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers PET Radiopharmaceuticals Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into PET Radiopharmaceuticals Market
3.7 Key Manufacturers PET Radiopharmaceuticals Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global PET Radiopharmaceuticals Market Size by Type
4.1 Global PET Radiopharmaceuticals Historic Market Review by Type (2016-2021)
4.1.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.1.3 PET Radiopharmaceuticals Price by Type (2016-2021)
4.2 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global PET Radiopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 PET Radiopharmaceuticals Price Forecast by Type (2022-2027)
5 Global PET Radiopharmaceuticals Market Size by Application
5.1 Global PET Radiopharmaceuticals Historic Market Review by Application (2016-2021)
5.1.1 Global PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.1.3 PET Radiopharmaceuticals Price by Application (2016-2021)
5.2 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global PET Radiopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 PET Radiopharmaceuticals Price Forecast by Application (2022-2027)
6 North America
6.1 North America PET Radiopharmaceuticals Sales Breakdown by Company
6.1.1 North America PET Radiopharmaceuticals Sales by Company (2016-2027)
6.1.2 North America PET Radiopharmaceuticals Revenue by Company (2016-2027)
6.2 North America PET Radiopharmaceuticals Market Size by Type (2016-2027)
6.2.1 North America PET Radiopharmaceuticals Sales by Type (2016-2027)
6.2.2 North America PET Radiopharmaceuticals Revenue by Type (2016-2027)
6.3 North America PET Radiopharmaceuticals Market Size by Application (2016-2027)
6.3.1 North America PET Radiopharmaceuticals Sales by Application (2016-2027)
6.3.2 North America PET Radiopharmaceuticals Revenue by Application (2016-2027)
6.4 North America PET Radiopharmaceuticals Market Size by Country
6.4.1 North America PET Radiopharmaceuticals Sales by Country (2016-2027)
6.4.2 North America PET Radiopharmaceuticals Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe PET Radiopharmaceuticals Sales Breakdown by Company
7.1.1 Europe PET Radiopharmaceuticals Sales by Company (2016-2027)
7.1.2 Europe PET Radiopharmaceuticals Revenue by Company (2016-2027)
7.2 Europe PET Radiopharmaceuticals Market Size by Type (2016-2027)
7.2.1 Europe PET Radiopharmaceuticals Sales by Type (2016-2027)
7.2.2 Europe PET Radiopharmaceuticals Revenue by Type (2016-2027)
7.3 Europe PET Radiopharmaceuticals Market Size by Application (2016-2027)
7.3.1 Europe PET Radiopharmaceuticals Sales by Application (2016-2027)
7.3.2 Europe PET Radiopharmaceuticals Revenue by Application (2016-2027)
7.4 Europe PET Radiopharmaceuticals Market Size by Country
7.4.1 Europe PET Radiopharmaceuticals Sales by Country (2016-2027)
7.4.2 Europe PET Radiopharmaceuticals Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific PET Radiopharmaceuticals Sales Breakdown by Company
8.1.1 Asia Pacific PET Radiopharmaceuticals Sales by Company (2016-2027)
8.1.2 Asia Pacific PET Radiopharmaceuticals Revenue by Company (2016-2027)
8.2 Asia Pacific PET Radiopharmaceuticals Market Size by Type (2016-2027)
8.2.1 Asia Pacific PET Radiopharmaceuticals Sales by Type (2016-2027)
8.2.2 Asia Pacific PET Radiopharmaceuticals Revenue by Type (2016-2027)
8.3 Asia Pacific PET Radiopharmaceuticals Market Size by Application (2016-2027)
8.3.1 Asia Pacific PET Radiopharmaceuticals Sales by Application (2016-2027)
8.3.2 Asia Pacific PET Radiopharmaceuticals Revenue by Application (2016-2027)
8.4 Asia Pacific PET Radiopharmaceuticals Market Size by Regions
8.4.1 Asia Pacific PET Radiopharmaceuticals Sales by Regions
8.4.2 Asia Pacific PET Radiopharmaceuticals Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America PET Radiopharmaceuticals Sales Breakdown by Company
9.1.1 Latin America PET Radiopharmaceuticals Sales by Company (2016-2027)
9.1.2 Latin America PET Radiopharmaceuticals Revenue by Company (2016-2027)
9.2 Latin America PET Radiopharmaceuticals Market Size by Type (2016-2027)
9.2.1 Latin America PET Radiopharmaceuticals Sales by Type (2016-2027)
9.2.2 Latin America PET Radiopharmaceuticals Revenue by Type (2016-2027)
9.3 Latin America PET Radiopharmaceuticals Market Size by Application (2016-2027)
9.3.1 Latin America PET Radiopharmaceuticals Sales by Application (2016-2027)
9.3.2 Latin America PET Radiopharmaceuticals Revenue by Application (2016-2027)
9.4 Latin America PET Radiopharmaceuticals Market Size by Country
9.4.1 Latin America PET Radiopharmaceuticals Sales by Country (2016-2027)
9.4.2 Latin America PET Radiopharmaceuticals Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa PET Radiopharmaceuticals Sales Breakdown by Company
10.1.1 Middle East and Africa PET Radiopharmaceuticals Sales by Company (2016-2027)
10.1.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Company (2016-2027)
10.2 Middle East and Africa PET Radiopharmaceuticals Market Size by Type (2016-2027)
10.2.1 Middle East and Africa PET Radiopharmaceuticals Sales by Type (2016-2027)
10.2.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Type (2016-2027)
10.3 Middle East and Africa PET Radiopharmaceuticals Market Size by Application (2016-2027)
10.3.1 Middle East and Africa PET Radiopharmaceuticals Sales by Application (2016-2027)
10.3.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2016-2027)
10.4 Middle East and Africa PET Radiopharmaceuticals Market Size by Country
10.4.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country (2016-2027)
10.4.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Cardinal Health Inc. (U.S.)
11.1.1 Cardinal Health Inc. (U.S.) Corporation Information
11.1.2 Cardinal Health Inc. (U.S.) Overview
11.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products and Services
11.1.5 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
11.1.6 Cardinal Health Inc. (U.S.) Recent Developments
11.2 Mallinckrodt plc (Ireland)
11.2.1 Mallinckrodt plc (Ireland) Corporation Information
11.2.2 Mallinckrodt plc (Ireland) Overview
11.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Products and Services
11.2.5 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals SWOT Analysis
11.2.6 Mallinckrodt plc (Ireland) Recent Developments
11.3 GE Healthcare (U.K.)
11.3.1 GE Healthcare (U.K.) Corporation Information
11.3.2 GE Healthcare (U.K.) Overview
11.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Products and Services
11.3.5 GE Healthcare (U.K.) PET Radiopharmaceuticals SWOT Analysis
11.3.6 GE Healthcare (U.K.) Recent Developments
11.4 Lantheus Medical Imaging, Inc. (U.S.)
11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
11.4.2 Lantheus Medical Imaging, Inc. (U.S.) Overview
11.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Products and Services
11.4.5 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
11.4.6 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
11.5 Bayer AG (Germany)
11.5.1 Bayer AG (Germany) Corporation Information
11.5.2 Bayer AG (Germany) Overview
11.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Products and Services
11.5.5 Bayer AG (Germany) PET Radiopharmaceuticals SWOT Analysis
11.5.6 Bayer AG (Germany) Recent Developments
11.6 Bracco Imaging S.p.A (Italy)
11.6.1 Bracco Imaging S.p.A (Italy) Corporation Information
11.6.2 Bracco Imaging S.p.A (Italy) Overview
11.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Products and Services
11.6.5 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals SWOT Analysis
11.6.6 Bracco Imaging S.p.A (Italy) Recent Developments
11.7 Eczacibasi-Monrol Nuclear Products (Turkey)
11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
11.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Overview
11.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Products and Services
11.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals SWOT Analysis
11.7.6 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
11.8 Nordion, Inc. (Canada)
11.8.1 Nordion, Inc. (Canada) Corporation Information
11.8.2 Nordion, Inc. (Canada) Overview
11.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Products and Services
11.8.5 Nordion, Inc. (Canada) PET Radiopharmaceuticals SWOT Analysis
11.8.6 Nordion, Inc. (Canada) Recent Developments
11.9 Advanced Accelerator Applications S.A. (France)
11.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information
11.9.2 Advanced Accelerator Applications S.A. (France) Overview
11.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Products and Services
11.9.5 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals SWOT Analysis
11.9.6 Advanced Accelerator Applications S.A. (France) Recent Developments
11.10 IBA Molecular Imaging (Belgium)
11.10.1 IBA Molecular Imaging (Belgium) Corporation Information
11.10.2 IBA Molecular Imaging (Belgium) Overview
11.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Products and Services
11.10.5 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals SWOT Analysis
11.10.6 IBA Molecular Imaging (Belgium) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 PET Radiopharmaceuticals Value Chain Analysis
12.2 PET Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 PET Radiopharmaceuticals Production Mode & Process
12.4 PET Radiopharmaceuticals Sales and Marketing
12.4.1 PET Radiopharmaceuticals Sales Channels
12.4.2 PET Radiopharmaceuticals Distributors
12.5 PET Radiopharmaceuticals Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 F-18
1.2.3 Ru-82
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global PET Radiopharmaceuticals Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global PET Radiopharmaceuticals Market Size (2016-2027)
2.1.1 Global PET Radiopharmaceuticals Revenue (2016-2027)
2.1.2 Global PET Radiopharmaceuticals Sales (2016-2027)
2.2 Global PET Radiopharmaceuticals Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global PET Radiopharmaceuticals Sales by Regions (2016-2021)
2.2.2 Global PET Radiopharmaceuticals Revenue by Regions (2016-2021)
2.3 Global PET Radiopharmaceuticals Market Size Forecast by Region
2.3.1 Global PET Radiopharmaceuticals Sales Forecast by Region (2022-2027)
2.3.2 Global PET Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4 Global Top PET Radiopharmaceuticals Regions (Countries) Ranking by Market Size
2.5 PET Radiopharmaceuticals Industry Trends
2.5.1 PET Radiopharmaceuticals Market Trends
2.5.2 PET Radiopharmaceuticals Market Drivers
2.5.3 PET Radiopharmaceuticals Market Challenges
2.5.4 PET Radiopharmaceuticals Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top PET Radiopharmaceuticals Manufacturers by Sales (2016-2021)
3.1.1 Global PET Radiopharmaceuticals Sales by Manufacturers (2016-2021)
3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by PET Radiopharmaceuticals Sales in 2020
3.2 Global Top Manufacturers PET Radiopharmaceuticals by Revenue
3.2.1 Global PET Radiopharmaceuticals Revenue by Manufacturers (2016-2021)
3.2.2 Top PET Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.2.3 Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
3.2.4 Global PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2020)
3.4 Global PET Radiopharmaceuticals Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers PET Radiopharmaceuticals Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into PET Radiopharmaceuticals Market
3.7 Key Manufacturers PET Radiopharmaceuticals Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global PET Radiopharmaceuticals Market Size by Type
4.1 Global PET Radiopharmaceuticals Historic Market Review by Type (2016-2021)
4.1.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.1.3 PET Radiopharmaceuticals Price by Type (2016-2021)
4.2 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global PET Radiopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 PET Radiopharmaceuticals Price Forecast by Type (2022-2027)
5 Global PET Radiopharmaceuticals Market Size by Application
5.1 Global PET Radiopharmaceuticals Historic Market Review by Application (2016-2021)
5.1.1 Global PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.1.3 PET Radiopharmaceuticals Price by Application (2016-2021)
5.2 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global PET Radiopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 PET Radiopharmaceuticals Price Forecast by Application (2022-2027)
6 North America
6.1 North America PET Radiopharmaceuticals Sales Breakdown by Company
6.1.1 North America PET Radiopharmaceuticals Sales by Company (2016-2027)
6.1.2 North America PET Radiopharmaceuticals Revenue by Company (2016-2027)
6.2 North America PET Radiopharmaceuticals Market Size by Type (2016-2027)
6.2.1 North America PET Radiopharmaceuticals Sales by Type (2016-2027)
6.2.2 North America PET Radiopharmaceuticals Revenue by Type (2016-2027)
6.3 North America PET Radiopharmaceuticals Market Size by Application (2016-2027)
6.3.1 North America PET Radiopharmaceuticals Sales by Application (2016-2027)
6.3.2 North America PET Radiopharmaceuticals Revenue by Application (2016-2027)
6.4 North America PET Radiopharmaceuticals Market Size by Country
6.4.1 North America PET Radiopharmaceuticals Sales by Country (2016-2027)
6.4.2 North America PET Radiopharmaceuticals Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe PET Radiopharmaceuticals Sales Breakdown by Company
7.1.1 Europe PET Radiopharmaceuticals Sales by Company (2016-2027)
7.1.2 Europe PET Radiopharmaceuticals Revenue by Company (2016-2027)
7.2 Europe PET Radiopharmaceuticals Market Size by Type (2016-2027)
7.2.1 Europe PET Radiopharmaceuticals Sales by Type (2016-2027)
7.2.2 Europe PET Radiopharmaceuticals Revenue by Type (2016-2027)
7.3 Europe PET Radiopharmaceuticals Market Size by Application (2016-2027)
7.3.1 Europe PET Radiopharmaceuticals Sales by Application (2016-2027)
7.3.2 Europe PET Radiopharmaceuticals Revenue by Application (2016-2027)
7.4 Europe PET Radiopharmaceuticals Market Size by Country
7.4.1 Europe PET Radiopharmaceuticals Sales by Country (2016-2027)
7.4.2 Europe PET Radiopharmaceuticals Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific PET Radiopharmaceuticals Sales Breakdown by Company
8.1.1 Asia Pacific PET Radiopharmaceuticals Sales by Company (2016-2027)
8.1.2 Asia Pacific PET Radiopharmaceuticals Revenue by Company (2016-2027)
8.2 Asia Pacific PET Radiopharmaceuticals Market Size by Type (2016-2027)
8.2.1 Asia Pacific PET Radiopharmaceuticals Sales by Type (2016-2027)
8.2.2 Asia Pacific PET Radiopharmaceuticals Revenue by Type (2016-2027)
8.3 Asia Pacific PET Radiopharmaceuticals Market Size by Application (2016-2027)
8.3.1 Asia Pacific PET Radiopharmaceuticals Sales by Application (2016-2027)
8.3.2 Asia Pacific PET Radiopharmaceuticals Revenue by Application (2016-2027)
8.4 Asia Pacific PET Radiopharmaceuticals Market Size by Regions
8.4.1 Asia Pacific PET Radiopharmaceuticals Sales by Regions
8.4.2 Asia Pacific PET Radiopharmaceuticals Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America PET Radiopharmaceuticals Sales Breakdown by Company
9.1.1 Latin America PET Radiopharmaceuticals Sales by Company (2016-2027)
9.1.2 Latin America PET Radiopharmaceuticals Revenue by Company (2016-2027)
9.2 Latin America PET Radiopharmaceuticals Market Size by Type (2016-2027)
9.2.1 Latin America PET Radiopharmaceuticals Sales by Type (2016-2027)
9.2.2 Latin America PET Radiopharmaceuticals Revenue by Type (2016-2027)
9.3 Latin America PET Radiopharmaceuticals Market Size by Application (2016-2027)
9.3.1 Latin America PET Radiopharmaceuticals Sales by Application (2016-2027)
9.3.2 Latin America PET Radiopharmaceuticals Revenue by Application (2016-2027)
9.4 Latin America PET Radiopharmaceuticals Market Size by Country
9.4.1 Latin America PET Radiopharmaceuticals Sales by Country (2016-2027)
9.4.2 Latin America PET Radiopharmaceuticals Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa PET Radiopharmaceuticals Sales Breakdown by Company
10.1.1 Middle East and Africa PET Radiopharmaceuticals Sales by Company (2016-2027)
10.1.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Company (2016-2027)
10.2 Middle East and Africa PET Radiopharmaceuticals Market Size by Type (2016-2027)
10.2.1 Middle East and Africa PET Radiopharmaceuticals Sales by Type (2016-2027)
10.2.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Type (2016-2027)
10.3 Middle East and Africa PET Radiopharmaceuticals Market Size by Application (2016-2027)
10.3.1 Middle East and Africa PET Radiopharmaceuticals Sales by Application (2016-2027)
10.3.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2016-2027)
10.4 Middle East and Africa PET Radiopharmaceuticals Market Size by Country
10.4.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country (2016-2027)
10.4.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Cardinal Health Inc. (U.S.)
11.1.1 Cardinal Health Inc. (U.S.) Corporation Information
11.1.2 Cardinal Health Inc. (U.S.) Overview
11.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products and Services
11.1.5 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
11.1.6 Cardinal Health Inc. (U.S.) Recent Developments
11.2 Mallinckrodt plc (Ireland)
11.2.1 Mallinckrodt plc (Ireland) Corporation Information
11.2.2 Mallinckrodt plc (Ireland) Overview
11.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Products and Services
11.2.5 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals SWOT Analysis
11.2.6 Mallinckrodt plc (Ireland) Recent Developments
11.3 GE Healthcare (U.K.)
11.3.1 GE Healthcare (U.K.) Corporation Information
11.3.2 GE Healthcare (U.K.) Overview
11.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Products and Services
11.3.5 GE Healthcare (U.K.) PET Radiopharmaceuticals SWOT Analysis
11.3.6 GE Healthcare (U.K.) Recent Developments
11.4 Lantheus Medical Imaging, Inc. (U.S.)
11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
11.4.2 Lantheus Medical Imaging, Inc. (U.S.) Overview
11.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Products and Services
11.4.5 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
11.4.6 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
11.5 Bayer AG (Germany)
11.5.1 Bayer AG (Germany) Corporation Information
11.5.2 Bayer AG (Germany) Overview
11.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Products and Services
11.5.5 Bayer AG (Germany) PET Radiopharmaceuticals SWOT Analysis
11.5.6 Bayer AG (Germany) Recent Developments
11.6 Bracco Imaging S.p.A (Italy)
11.6.1 Bracco Imaging S.p.A (Italy) Corporation Information
11.6.2 Bracco Imaging S.p.A (Italy) Overview
11.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Products and Services
11.6.5 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals SWOT Analysis
11.6.6 Bracco Imaging S.p.A (Italy) Recent Developments
11.7 Eczacibasi-Monrol Nuclear Products (Turkey)
11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
11.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Overview
11.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Products and Services
11.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals SWOT Analysis
11.7.6 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
11.8 Nordion, Inc. (Canada)
11.8.1 Nordion, Inc. (Canada) Corporation Information
11.8.2 Nordion, Inc. (Canada) Overview
11.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Products and Services
11.8.5 Nordion, Inc. (Canada) PET Radiopharmaceuticals SWOT Analysis
11.8.6 Nordion, Inc. (Canada) Recent Developments
11.9 Advanced Accelerator Applications S.A. (France)
11.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information
11.9.2 Advanced Accelerator Applications S.A. (France) Overview
11.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Products and Services
11.9.5 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals SWOT Analysis
11.9.6 Advanced Accelerator Applications S.A. (France) Recent Developments
11.10 IBA Molecular Imaging (Belgium)
11.10.1 IBA Molecular Imaging (Belgium) Corporation Information
11.10.2 IBA Molecular Imaging (Belgium) Overview
11.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Products and Services
11.10.5 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals SWOT Analysis
11.10.6 IBA Molecular Imaging (Belgium) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 PET Radiopharmaceuticals Value Chain Analysis
12.2 PET Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 PET Radiopharmaceuticals Production Mode & Process
12.4 PET Radiopharmaceuticals Sales and Marketing
12.4.1 PET Radiopharmaceuticals Sales Channels
12.4.2 PET Radiopharmaceuticals Distributors
12.5 PET Radiopharmaceuticals Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
